chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: Body aches; Pain; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PAIN (Pain), CHILLS (Chills) and HEADACHE (Headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN (Body aches), PAIN (Pain), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, PAIN (Body aches), PAIN (Pain), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Medication not provided by the reporter.  Treatment information was not provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Vomiting
Clinical narrative: some aches; Nausea; Vomitting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (some aches), NAUSEA (Nausea) and VOMITING (Vomitting) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced PAIN (some aches), NAUSEA (Nausea) and VOMITING (Vomitting). At the time of the report, PAIN (some aches), NAUSEA (Nausea) and VOMITING (Vomitting) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant Medication not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain, Back pain, Chest discomfort, Chills
Clinical narrative: Heaviness in my chest / tightness in my chest; Severe abdominal pain; Low back ache; Severe abdominal discomfort; Lupus rash (neck, trunk, chest, then my arms and legs on the next day); No appetite; Chills; Fever (103°F); Fatigue; Soreness @ injection site; Swelling @ injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort) and SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020. Concurrent medical conditions included Cutaneous lupus erythematosus.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced HEADACHE (Headache). On 26-Jan-2021, the patient experienced CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort), SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)), DECREASED APPETITE (No appetite), CHILLS (Chills), PYREXIA (Fever (103°F)), FATIGUE (Fatigue), VACCINATION SITE PAIN (Soreness @ injection site) and VACCINATION SITE SWELLING (Swelling @ injection site). At the time of the report, CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort), SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)), DECREASED APPETITE (No appetite), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Fever (103°F)), FATIGUE (Fatigue), VACCINATION SITE PAIN (Soreness @ injection site) and VACCINATION SITE SWELLING (Swelling @ injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Pyrexia, Systemic lupus erythematosus rash
Clinical narrative: Heaviness in my chest / tightness in my chest; Severe abdominal pain; Low back ache; Severe abdominal discomfort; Lupus rash (neck, trunk, chest, then my arms and legs on the next day); No appetite; Chills; Fever (103°F); Fatigue; Soreness @ injection site; Swelling @ injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort) and SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020. Concurrent medical conditions included Cutaneous lupus erythematosus.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced HEADACHE (Headache). On 26-Jan-2021, the patient experienced CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort), SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)), DECREASED APPETITE (No appetite), CHILLS (Chills), PYREXIA (Fever (103°F)), FATIGUE (Fatigue), VACCINATION SITE PAIN (Soreness @ injection site) and VACCINATION SITE SWELLING (Swelling @ injection site). At the time of the report, CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort), SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)), DECREASED APPETITE (No appetite), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Fever (103°F)), FATIGUE (Fatigue), VACCINATION SITE PAIN (Soreness @ injection site) and VACCINATION SITE SWELLING (Swelling @ injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Heaviness in my chest / tightness in my chest; Severe abdominal pain; Low back ache; Severe abdominal discomfort; Lupus rash (neck, trunk, chest, then my arms and legs on the next day); No appetite; Chills; Fever (103°F); Fatigue; Soreness @ injection site; Swelling @ injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort) and SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in March 2020. Concurrent medical conditions included Cutaneous lupus erythematosus.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced HEADACHE (Headache). On 26-Jan-2021, the patient experienced CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort), SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)), DECREASED APPETITE (No appetite), CHILLS (Chills), PYREXIA (Fever (103°F)), FATIGUE (Fatigue), VACCINATION SITE PAIN (Soreness @ injection site) and VACCINATION SITE SWELLING (Swelling @ injection site). At the time of the report, CHEST DISCOMFORT (Heaviness in my chest / tightness in my chest), ABDOMINAL PAIN (Severe abdominal pain), BACK PAIN (Low back ache), ABDOMINAL DISCOMFORT (Severe abdominal discomfort), SYSTEMIC LUPUS ERYTHEMATOSUS RASH (Lupus rash (neck, trunk, chest, then my arms and legs on the next day)), DECREASED APPETITE (No appetite), HEADACHE (Headache), CHILLS (Chills), PYREXIA (Fever (103°F)), FATIGUE (Fatigue), VACCINATION SITE PAIN (Soreness @ injection site) and VACCINATION SITE SWELLING (Swelling @ injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Redness at the injection site and red/red streak down the arm went away after 3 days; site was really red and sore; red, itching rash came back on her arm and lasted about 11 days; itching rash came back on her arm and lasted about 11 days; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at the injection site and red/red streak down the arm went away after 3 days), VACCINATION SITE PAIN (site was really red and sore), VACCINATION SITE ERYTHEMA (red, itching rash came back on her arm and lasted about 11 days) and VACCINATION SITE PRURITUS (itching rash came back on her arm and lasted about 11 days) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site and red/red streak down the arm went away after 3 days), VACCINATION SITE PAIN (site was really red and sore), VACCINATION SITE ERYTHEMA (red, itching rash came back on her arm and lasted about 11 days) and VACCINATION SITE PRURITUS (itching rash came back on her arm and lasted about 11 days). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site reaction, at an unspecified dose and frequency. On 20-Jan-2021, VACCINATION SITE ERYTHEMA (Redness at the injection site and red/red streak down the arm went away after 3 days) had resolved. On 28-Jan-2021, VACCINATION SITE ERYTHEMA (red, itching rash came back on her arm and lasted about 11 days) and VACCINATION SITE PRURITUS (itching rash came back on her arm and lasted about 11 days) had resolved. At the time of the report, VACCINATION SITE PAIN (site was really red and sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant Medication not provided by the reporter.   This case was linked to MOD-2021-011101 (Parent-Child Link). This case was linked to MOD-2021-011101 (Patient Link).   See case MOD-2021-011101 for details regarding the child case.  Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: No specific follow-up information recorded.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: Under the armpit it feels tender; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Under the armpit it feels tender) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 040A20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 17-Feb-2021 at 5:50 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021 at 5:50 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (Under the armpit it feels tender). At the time of the report, AXILLARY PAIN (Under the armpit it feels tender) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment details not provided by the reporter.  The tenderness started a couple  of days after the first dose and was gone approximately 4 to 5 days later.    Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Reporter details updated, patient's demographics updated, second dose vaccine information added and outcome of the event was updated from unknown to recovered.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Fatigue, Nausea, Oropharyngeal pain, Vomiting
Clinical narrative: Stomach hurting; sore throat; fatigue; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach hurting), OROPHARYNGEAL PAIN (sore throat), FATIGUE (fatigue), NAUSEA (nausea) and VOMITING (vomiting) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Cholesterol.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach hurting), OROPHARYNGEAL PAIN (sore throat), FATIGUE (fatigue), NAUSEA (nausea) and VOMITING (vomiting). In February 2021, OROPHARYNGEAL PAIN (sore throat) and VOMITING (vomiting) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (Stomach hurting), FATIGUE (fatigue) and NAUSEA (nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient take Tylenol and aspirin since 21Feb2021 as a Treatment medication    This case was linked to MOD-2021-022241, MOD-2021-022272.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain in her arm where the vaccine was injected; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in her arm where the vaccine was injected) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain in her arm where the vaccine was injected). At the time of the report, VACCINATION SITE PAIN (pain in her arm where the vaccine was injected) had resolved.            No concomitant medications were provided  No treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: follow-up received document Addition of second dose information added , outcome of event Vaccination site pain is changes from unknown to recovered, No further follow-up required.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Gingival discolouration, Gingival discomfort, Gingival pain, Gingival swelling
Clinical narrative: she felt very light headed; her top gum of the right hand side started getting very tingly; her top gum of the right hand side started burning; she could feel her gum swelling/really swollen; got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red; Burning like they were on fire/burning for all night long; her pinkie (little finger), and ring finger went numb on her right side,her forearm went numb; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (she felt very light headed), PARAESTHESIA ORAL (her top gum of the right hand side started getting very tingly), GINGIVAL PAIN (her top gum of the right hand side started burning), GINGIVAL SWELLING (she could feel her gum swelling/really swollen) and GINGIVAL DISCOLOURATION (got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included FAMOTIDINE, CETIRIZINE, TRIAMCINOLONE and SEMAGLUTIDE for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced HYPOAESTHESIA (her pinkie (little finger), and ring finger went numb on her right side,her forearm went numb). On 20-Feb-2021, the patient experienced DIZZINESS (she felt very light headed), PARAESTHESIA ORAL (her top gum of the right hand side started getting very tingly), GINGIVAL PAIN (her top gum of the right hand side started burning), GINGIVAL SWELLING (she could feel her gum swelling/really swollen), GINGIVAL DISCOLOURATION (got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red) and GINGIVAL DISCOMFORT (Burning like they were on fire/burning for all night long). On 21-Feb-2021, DIZZINESS (she felt very light headed), PARAESTHESIA ORAL (her top gum of the right hand side started getting very tingly), GINGIVAL PAIN (her top gum of the right hand side started burning), GINGIVAL SWELLING (she could feel her gum swelling/really swollen), GINGIVAL DISCOLOURATION (got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red), GINGIVAL DISCOMFORT (Burning like they were on fire/burning for all night long) and HYPOAESTHESIA (her pinkie (little finger), and ring finger went numb on her right side,her forearm went numb) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia oral
Clinical narrative: she felt very light headed; her top gum of the right hand side started getting very tingly; her top gum of the right hand side started burning; she could feel her gum swelling/really swollen; got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red; Burning like they were on fire/burning for all night long; her pinkie (little finger), and ring finger went numb on her right side,her forearm went numb; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (she felt very light headed), PARAESTHESIA ORAL (her top gum of the right hand side started getting very tingly), GINGIVAL PAIN (her top gum of the right hand side started burning), GINGIVAL SWELLING (she could feel her gum swelling/really swollen) and GINGIVAL DISCOLOURATION (got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included FAMOTIDINE, CETIRIZINE, TRIAMCINOLONE and SEMAGLUTIDE for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced HYPOAESTHESIA (her pinkie (little finger), and ring finger went numb on her right side,her forearm went numb). On 20-Feb-2021, the patient experienced DIZZINESS (she felt very light headed), PARAESTHESIA ORAL (her top gum of the right hand side started getting very tingly), GINGIVAL PAIN (her top gum of the right hand side started burning), GINGIVAL SWELLING (she could feel her gum swelling/really swollen), GINGIVAL DISCOLOURATION (got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red) and GINGIVAL DISCOMFORT (Burning like they were on fire/burning for all night long). On 21-Feb-2021, DIZZINESS (she felt very light headed), PARAESTHESIA ORAL (her top gum of the right hand side started getting very tingly), GINGIVAL PAIN (her top gum of the right hand side started burning), GINGIVAL SWELLING (she could feel her gum swelling/really swollen), GINGIVAL DISCOLOURATION (got red/her bottom right gum got red/the whole left side gum got red/super red/cherry red), GINGIVAL DISCOMFORT (Burning like they were on fire/burning for all night long) and HYPOAESTHESIA (her pinkie (little finger), and ring finger went numb on her right side,her forearm went numb) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: developed a severe headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (developed a severe headache) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (developed a severe headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, HEADACHE (developed a severe headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Pruritus
Clinical narrative: Itchiness all over the body/Itchiness in cycles; Discomfort; This spontaneous case was reported by a health care professional and describes the occurrence of PRURITUS (Itchiness all over the body/Itchiness in cycles) and DISCOMFORT (Discomfort) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 011H20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes since 1994, Blood pressure high since 1975, Hyperlipidaemia since 1985 and Penicillin allergy (Itching on the lips.Happened more than 50 years ago and she had not used it again.). Concomitant products included ATORVASTATIN for Cholesterol, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET XR) for Diabetes, IRBESARTAN and NIFEDIPINE for Hypertension.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced PRURITUS (Itchiness all over the body/Itchiness in cycles) and DISCOMFORT (Discomfort). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) from 21-Jan-2021 to 23-Jan-2021 at a dose of 50 mg three times a day. On 23-Jan-2021, PRURITUS (Itchiness all over the body/Itchiness in cycles) had resolved. At the time of the report, DISCOMFORT (Discomfort) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow-up information received on 30-JUN-2021. Reporter phone number updated, second dose added, action taken and event outcome updated.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Blood disorder
Clinical narrative: Blood thinner then before; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD DISORDER (Blood thinner then before) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029120A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced BLOOD DISORDER (Blood thinner then before). At the time of the report, BLOOD DISORDER (Blood thinner then before) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient is on blood thinner. Treatment details not provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Headache, Migraine, Peripheral swelling
Clinical narrative: Swollen; Hot; rash; big hives, sizes of a counter; Migraine and headache; Red arm; migraine and headache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine and headache), ERYTHEMA (Red arm), PERIPHERAL SWELLING (Swollen), FEELING HOT (Hot) and RASH (rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced MIGRAINE (Migraine and headache), ERYTHEMA (Red arm) and HEADACHE (migraine and headache). On 22-Feb-2021, the patient experienced RASH (rash) and URTICARIA (big hives, sizes of a counter). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen) and FEELING HOT (Hot). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) for Hives, at an unspecified dose and frequency. On 20-Feb-2021, MIGRAINE (Migraine and headache) and HEADACHE (migraine and headache) had resolved. At the time of the report, ERYTHEMA (Red arm), RASH (rash) and URTICARIA (big hives, sizes of a counter) had not resolved and PERIPHERAL SWELLING (Swollen) and FEELING HOT (Hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Swollen; Hot; rash; big hives, sizes of a counter; Migraine and headache; Red arm; migraine and headache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine and headache), ERYTHEMA (Red arm), PERIPHERAL SWELLING (Swollen), FEELING HOT (Hot) and RASH (rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced MIGRAINE (Migraine and headache), ERYTHEMA (Red arm) and HEADACHE (migraine and headache). On 22-Feb-2021, the patient experienced RASH (rash) and URTICARIA (big hives, sizes of a counter). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen) and FEELING HOT (Hot). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) for Hives, at an unspecified dose and frequency. On 20-Feb-2021, MIGRAINE (Migraine and headache) and HEADACHE (migraine and headache) had resolved. At the time of the report, ERYTHEMA (Red arm), RASH (rash) and URTICARIA (big hives, sizes of a counter) had not resolved and PERIPHERAL SWELLING (Swollen) and FEELING HOT (Hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Dizziness, Extremity contracture, Fatigue, Hypoaesthesia
Clinical narrative: dizziness; clamminess; lost feeling in my arms, wrist; fingers curled; pain at the injection site; Fatigue; bodyaches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled) and VACCINATION SITE PAIN (pain at the injection site) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled), VACCINATION SITE PAIN (pain at the injection site), FATIGUE (Fatigue), MYALGIA (bodyaches) and NAUSEA (Nausea). At the time of the report, DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled), VACCINATION SITE PAIN (pain at the injection site), FATIGUE (Fatigue), MYALGIA (bodyaches) and NAUSEA (Nausea) had not resolved.            No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Vaccination site pain
Clinical narrative: dizziness; clamminess; lost feeling in my arms, wrist; fingers curled; pain at the injection site; Fatigue; bodyaches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled) and VACCINATION SITE PAIN (pain at the injection site) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled), VACCINATION SITE PAIN (pain at the injection site), FATIGUE (Fatigue), MYALGIA (bodyaches) and NAUSEA (Nausea). At the time of the report, DIZZINESS (dizziness), COLD SWEAT (clamminess), HYPOAESTHESIA (lost feeling in my arms, wrist), EXTREMITY CONTRACTURE (fingers curled), VACCINATION SITE PAIN (pain at the injection site), FATIGUE (Fatigue), MYALGIA (bodyaches) and NAUSEA (Nausea) had not resolved.            No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Feeling abnormal, Malaise, Muscular weakness
Clinical narrative: muscular problems; chills; fever; nauseas; body pain; diarrhea; night sweats; didn't feel well; felt funny; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body pain), DIARRHOEA (diarrhea), NIGHT SWEATS (night sweats), MALAISE (didn't feel well) and FEELING ABNORMAL (felt funny) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Test was negative but he had all the symptoms for 6 weeks) on 31-Oct-2020.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN (body pain), DIARRHOEA (diarrhea), NIGHT SWEATS (night sweats), MALAISE (didn't feel well), FEELING ABNORMAL (felt funny), CHILLS (chills), PYREXIA (fever) and NAUSEA (nauseas). On 22-Feb-2021, the patient experienced MUSCULAR WEAKNESS (muscular problems). At the time of the report, PAIN (body pain), DIARRHOEA (diarrhea), NIGHT SWEATS (night sweats), MALAISE (didn't feel well), FEELING ABNORMAL (felt funny), MUSCULAR WEAKNESS (muscular problems), CHILLS (chills), PYREXIA (fever) and NAUSEA (nauseas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided No treatment information provided    Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Night sweats, Pain, Pyrexia
Clinical narrative: muscular problems; chills; fever; nauseas; body pain; diarrhea; night sweats; didn't feel well; felt funny; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body pain), DIARRHOEA (diarrhea), NIGHT SWEATS (night sweats), MALAISE (didn't feel well) and FEELING ABNORMAL (felt funny) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Test was negative but he had all the symptoms for 6 weeks) on 31-Oct-2020.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN (body pain), DIARRHOEA (diarrhea), NIGHT SWEATS (night sweats), MALAISE (didn't feel well), FEELING ABNORMAL (felt funny), CHILLS (chills), PYREXIA (fever) and NAUSEA (nauseas). On 22-Feb-2021, the patient experienced MUSCULAR WEAKNESS (muscular problems). At the time of the report, PAIN (body pain), DIARRHOEA (diarrhea), NIGHT SWEATS (night sweats), MALAISE (didn't feel well), FEELING ABNORMAL (felt funny), MUSCULAR WEAKNESS (muscular problems), CHILLS (chills), PYREXIA (fever) and NAUSEA (nauseas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided No treatment information provided    Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Left arm was hurting at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm was hurting at injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (Left arm was hurting at injection site). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site pain, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PAIN (Left arm was hurting at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Additional information received included no new information.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Adverse reaction, Decreased appetite, Fatigue, Nausea
Clinical narrative: stomach hurting; he is not hungry, he does not eat; has lost like 3 poungds but he does not feel critical; Symptoms still ongoing; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach hurting), DECREASED APPETITE (he is not hungry, he does not eat), WEIGHT DECREASED (has lost like 3 poungds but he does not feel critical), ADVERSE REACTION (Symptoms still ongoing) and NAUSEA (nausea) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and Cholesterol.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach hurting), DECREASED APPETITE (he is not hungry, he does not eat), WEIGHT DECREASED (has lost like 3 poungds but he does not feel critical), ADVERSE REACTION (Symptoms still ongoing), NAUSEA (nausea) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) on 21-Feb-2021 for Nausea and Abdominal pain, at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPRIN) on 21-Feb-2021 for Nausea and Abdominal pain, at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (stomach hurting), DECREASED APPETITE (he is not hungry, he does not eat), WEIGHT DECREASED (has lost like 3 poungds but he does not feel critical), ADVERSE REACTION (Symptoms still ongoing), NAUSEA (nausea) and FATIGUE (fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-036175, MOD21-036214 (E2B Linked Report).; Sender's Comments:  MOD21-036175: MOD21-036214:
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: stomach hurting; he is not hungry, he does not eat; has lost like 3 poungds but he does not feel critical; Symptoms still ongoing; nausea; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach hurting), DECREASED APPETITE (he is not hungry, he does not eat), WEIGHT DECREASED (has lost like 3 poungds but he does not feel critical), ADVERSE REACTION (Symptoms still ongoing) and NAUSEA (nausea) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and Cholesterol.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach hurting), DECREASED APPETITE (he is not hungry, he does not eat), WEIGHT DECREASED (has lost like 3 poungds but he does not feel critical), ADVERSE REACTION (Symptoms still ongoing), NAUSEA (nausea) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) on 21-Feb-2021 for Nausea and Abdominal pain, at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPRIN) on 21-Feb-2021 for Nausea and Abdominal pain, at an unspecified dose and frequency. At the time of the report, ABDOMINAL PAIN UPPER (stomach hurting), DECREASED APPETITE (he is not hungry, he does not eat), WEIGHT DECREASED (has lost like 3 poungds but he does not feel critical), ADVERSE REACTION (Symptoms still ongoing), NAUSEA (nausea) and FATIGUE (fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-036175, MOD21-036214 (E2B Linked Report).; Sender's Comments:  MOD21-036175: MOD21-036214:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: scratching, itchiness at site of injection; rash in area of injection 2 in diameter; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (scratching, itchiness at site of injection) and VACCINATION SITE RASH (rash in area of injection 2 in diameter) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (scratching, itchiness at site of injection) and VACCINATION SITE RASH (rash in area of injection 2 in diameter). At the time of the report, VACCINATION SITE PRURITUS (scratching, itchiness at site of injection) and VACCINATION SITE RASH (rash in area of injection 2 in diameter) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Neosporin taken as a Treatment medication.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash, Injection site urticaria, Injection site warmth
Clinical narrative: hives around injection site; rash around injection site; itchiness at injection site; warmth at injection site; bump at the injection site; A spontaneous report was received from a consumer concerning a 35-year-old, mfeale patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced injection site urticaria,injection site pruritis,injection site warmth,injection site mass and injection site rash.  The patient's medical history was unknown.. Concomitant medications were unknown. On 21-JAN-2021  prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 21-JAN-2021, prior to receiving mRNA-1273, the patient felt warmth and a bump at the injection site and went away followed by random itchiness  and on 27-JAN-2021 injection site warm and itchy surrounded by a rash and hives.  Treatment for the events was unknown. Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events,injection site mass , were considered resolved  and outcome of injection site urticaria,injection site pruritis,injection site warmth,injection site rash were considered unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: bad case of diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (bad case of diarrhea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced DIARRHOEA (bad case of diarrhea). On 29-Jan-2021, DIARRHOEA (bad case of diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details not provided
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Headache, Nausea
Clinical narrative: couldn't eat; Vomited; Very weak/felt so weak; Chills; Nausea; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (couldn't eat), ASTHENIA (Very weak/felt so weak), CHILLS (Chills), NAUSEA (Nausea) and HEADACHE (Headache) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Autoimmune disorder NOS (two autoimmune diseases, one in eye). Concomitant products included METHOTREXATE for an unknown indication.   On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced ASTHENIA (Very weak/felt so weak), CHILLS (Chills), NAUSEA (Nausea) and HEADACHE (Headache). On 21-Feb-2021, the patient experienced DECREASED APPETITE (couldn't eat) and VOMITING (Vomited). On 17-Feb-2021, HEADACHE (Headache) had resolved. On 21-Feb-2021, VOMITING (Vomited) had resolved. At the time of the report, DECREASED APPETITE (couldn't eat), ASTHENIA (Very weak/felt so weak), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.            No treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow up information received on 29-jun-2021 contains email address updated